THEMIS MEDICARE
Back to Cashflow Statement
|
THEMIS MEDICARE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-26 Cr | ₹-8.77 Cr | ₹0.14 Cr | ₹-18 Cr | ₹-26 Cr |
What is the latest Cash Flow from Financing Activities ratio of THEMIS MEDICARE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-26 Cr |
| Mar2024 | ₹-8.77 Cr |
| Mar2023 | ₹0.14 Cr |
| Mar2022 | ₹-18 Cr |
| Mar2021 | ₹-26 Cr |
How is Cash Flow from Financing Activities of THEMIS MEDICARE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-26 Cr | Negative | |
| Mar2024 | ₹-8.77 Cr | Negative | |
| Mar2023 | ₹0.14 Cr | Positive | |
| Mar2022 | ₹-18 Cr | Negative | |
| Mar2021 | ₹-26 Cr | - | |
Compare Cash Flow from Financing Activities of peers of THEMIS MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THEMIS MEDICARE | ₹1,110.7 Cr | -2.9% | 7.1% | 24.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
THEMIS MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THEMIS MEDICARE | -2.9% |
7.1% |
24.3% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses